Received Feb 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 255t2 | IM / RA |
Patient received RSV in October 2023. Software and agency did not recall she had RSV in October of 2023 and requested vaccine. I called patient on 2/5/2025 to follow up with her well being and she reported no SE or reaction from 2nd shot.